P45 IL-2 THERAPY REDUCES RENAL INFLAMMATION AND CELLULAR ACTIVITY OF INTRARENAL CD4+ CONVENTIONAL T CELLS IN LUPUS PRONE MICE WITH ACTIVE LUPUS NEPHRITIS

• A. Rose,
• C. von Spee-Mayer,
• L. Kloke,
• K. Wu,
• P. Enghard,
• A. Kühl,
• J.Y. Humrich,
• G. Riemekasten

Affiliations

A. Rose

Charité, Rheumatology and Clinical Immunology, Berlin, Germany

C. von Spee-Mayer

Charité, Rheumatology and Clinical Immunology, Berlin, Germany

L. Kloke

Technical University Berlin, Institute for Biotechnology, Berlin, Germany

K. Wu

Charité, Department of Nephrology, Berlin, Germany

P. Enghard

Charité, Department of Nephrology and Intensive Care Medicine, Berlin, Germany

A. Kühl

Charité, Research Center ImmunoSciences RCIS, Berlin, Germany

J.Y. Humrich

University Hospital Schleswig-Holstein, Department of Rheumatology, Lübeck, Germany

G. Riemekasten

University Hospital Schleswig-Holstein, Department of Rheumatology, Lübeck, Germany